Skip to main content
International Health logoLink to International Health
. 2025 Dec 22;18(4):555–556. doi: 10.1093/inthealth/ihaf154

Air pollution and lung cancer in India: an escalating public health crisis

Tarun Kumar Suvvari 1,2,3,✉, Nithya Arigapudi 4,5, Shreya Veggalam 6
PMCID: PMC13329964  PMID: 41428367

Dear Editor,

Lung cancer has long been considered a smoker’s disease. Yet in India, a strikingly different narrative is emerging: one driven not by tobacco, but by toxic air.1 With some of the world’s highest concentrations of fine particulate matter (PM₂.₅), India faces a silent but escalating cases of lung cancer due to air pollution.2 With ambient fine PM₂.₅ levels routinely exceeding 100 µg/m³ in many urban centres, the risk posed by air pollution as a carcinogen deserves urgent attention.1,2 Ambient air pollution is now classified by the International Agency for Research on Cancer as a Group 1 human carcinogen.3 Exposure to major ambient air pollutants shows a significant association with both the incidence and mortality of cancer, particularly lung cancer.4

While tobacco remains the leading cause of lung cancer, there is an emerging and troubling trend of increasing incidence among never-smokers, particularly in India, where exposure to ambient and household air pollution is pervasive. Noronha et al. reported that, in India, 40–50% of lung cancer cases occur in never-smokers, with the proportion rising to as high as 83% among Indian women, highlighting the growing contribution of air pollution and biomass fuel exposure to the country’s lung cancer burden.5 Estimates from the India State-Level Disease Burden Initiative Air Pollution Collaborators (GBD 2019) indicate that lung cancer accounted for 1.3% of all air pollution-attributable disability-adjusted life-years nationally, a seemingly modest fraction that nevertheless translates into a considerable absolute burden given India’s large population and high levels of both ambient and household particulate exposure.6 The economic burden attributable to air pollution in India was estimated at US$36.8 billion in 2019, of which lung cancer accounted for 1.2%, reflecting substantial productivity loss and treatment expenditure. Although this share is smaller than that of other respiratory conditions, its growth reflects India’s ongoing epidemiological transition and increasing exposure to ambient PM₂.₅.6 One striking finding is that, from 1990 to 2019, deaths attributable to household air pollution declined markedly (64.2%), whereas those linked to ambient PM₂.₅ pollution rose by 115.3%.6 So, the above studies highlight that air pollution is a key non-tobacco driver of India’s lung cancer epidemic.

For clinicians and policymakers, the implications of this epidemiological shift are profound. Current low-dose CT screening guidelines (largely derived in high-income settings and focused on heavy smokers) fail to account for environmental exposures as primary risk factors.7 Consequently, the non-smoking population—particularly in highly polluted urban areas—is often excluded from screening, leading to the devastating diagnosis of advanced-stage lung cancer, where curative options are limited. In India, incorporating airborne-pollution exposure history into risk-stratification algorithms may help to identify high-risk individuals among never-smokers and prompt earlier detection. From a public health perspective, targeting ambient pollution is itself an onco-preventive strategy. Reductions in PM₂.₅ levels translate not only to fewer respiratory and cardiovascular deaths, but may also prevent cancers. The Indian Government’s National Clean Air Programme aims for a 20–30% reduction in PM₂.₅ by 2024–2025, but achieving this target remains a challenge given the scale of industrial, vehicular and agricultural emissions.8 So, surveillance programmes and cancer registries should increasingly incorporate geospatial pollution data. Collaborative research is needed to define dose–response curves, histological subtype associations (e.g. adenocarcinoma in never-smokers) and to assess whether pollution modifies treatment outcomes or prognosis. Mitigation of this crisis demands multisectoral action, that is, stricter emission standards, investment in clean energy and integration of air-quality health metrics into cancer-control programmes. Reducing air pollution is not only an environmental imperative, but also an onco-preventive intervention.

In conclusion, lung cancer in India must no longer be viewed solely through the lens of tobacco.

We are witnessing a hidden epidemic of lung cancer driven by air pollution, and overlooking it means ignoring a preventable cause of cancer. Each delay in clean-air action adds to the cancer registry of tomorrow.

Contributor Information

Tarun Kumar Suvvari, Academic Scholar, Institute of Epidemiology and Health Care, University College London (UCL), 1-19 Torrington Pl, London, WC1E 7HB, UK; Academic Scholar, Indraprastha Institute of Information Technology (IIIT) Delhi, Okhla Industrial Estate, Phase III, Near Govind Puri Metro Station, New Delhi 110020, India; Global Health Research Group (GHRG), Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh 532185, India.

Nithya Arigapudi, Global Health Research Group (GHRG), Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh 532185, India; PGY1, Penn State College of Medicine, 700 HMC Crescent Road, Hershey, PA 17033, USA.

Shreya Veggalam, Global Health Research Group (GHRG), Squad Medicine and Research (SMR), Amadalavalasa, Andhra Pradesh 532185, India.

Author contributions

Tarun Kumar Suvvari (Conceptualization, Resources, Writing—original draft, Writing—review & editing), Nithya Arigapudi (Conceptualization, Resources, Writing—original draft, Writing—review & editing, Project Administration), and Shreya Veggalam (Resources, Writing—original draft, Writing—review & editing, Supervision).

Funding

No funding was received.

Competing interests

The authors declare no conflicts of interests.

Data availability

Not applicable.

Informed consent

Not applicable.

Declaration of generative AI and AI-assisted technologies in the manuscript preparation process

No AI or AI tools were used while drafting the manuscript. However, Grammarly tool was used to correct the grammar in the manuscript.

References

  • 1. National Cancer Registry Programme Investigator Group, Mathur  P, Sathishkumar  K  et al.  Cancer incidence and mortality across 43 Cancer registries in India. JAMA Netw Open. 2025;8:e2527805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Khilnani  GC, Tiwari  P. Air pollution in India and related adverse respiratory health effects: past, present, and future directions. Curr Opin Pulm Med. 2018;24:108–16. [DOI] [PubMed] [Google Scholar]
  • 3. IARC Working Group  on the evaluation of carcinogenic risks to humans. Outdoor air pollution. IARC Monogr Eval Carcinog Risks Hum. 2016;109:9–444. [PMC free article] [PubMed] [Google Scholar]
  • 4. Ramamoorthy  T, Nath  A, Singh  S  et al.  Assessing the global impact of ambient air pollution on cancer incidence and mortality: a comprehensive meta-analysis. JCO Glob Oncol. 2024;10:e2300427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Noronha  V, Budukh  A, Chaturvedi  P  et al.  Uniqueness of lung cancer in Southeast Asia. Lancet Reg Health Southeast Asia. 2024;27:100430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. India State-Level Disease Burden Initiative Air Pollution Collaborators . Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. Lancet Planet Health. 2021;5:e25–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Khanna  VK, Ghosh  S, MacMahon  H  et al.  Criteria for low-dose CT lung cancer screening in the setting of air pollution: a discussion that is long overdue. Chest. 2021;159:42–5. [DOI] [PubMed] [Google Scholar]
  • 8. Gopikrishnan  GS, Kuttippurath  J. Impact of the National Clean Air Programme (NCAP) on the particulate matter pollution and associated reduction in human mortalities in Indian cities. Sci Total Environ. 2025;968:178787. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from International Health are provided here courtesy of Oxford University Press

RESOURCES